Bruce Clark
CEO and Director
With over 30 years of diverse experience in management and production across multiple industries, Bruce Clark leads Nirvana as CEO and Director. His profound understanding of public policy and the significance of collaboration with government and health professionals enriches his approach to addressing some of society’s most challenging issues.
Annie Storey
CFO
Annie Storey brings over two decades of experience in finance, accounting, and management across sectors such as energy, mining, and health science. A respected advisor and director for various companies, Annie also contributes to societal change as a Director of “Moms Stop the Harm” and is a member of the Chartered Professional Accountants of Canada and British Columbia.
Robert August
Chief Chemist and Head of Innovation
Robert August is a trailblazer in medicinal chemistry with a specific focus on psychoactive and psychedelic compounds. As the co-founder of the Berkeley-Clearlight Research Group at Purdue University, he has pioneered the synthesis of groundbreaking compounds, including being the first to synthesize 3,4-MDMA Monohydrate HCl as a crystalline solid.
Sheldon Inwentash
Chairman of the Board
Sheldon Inwentash, Chairman and CEO of ThreeD Capital Inc., has over 30 years of investment experience. His strategic foresight has significantly enhanced shareholder value, and his entrepreneurial leadership has earned him recognition, including an honorary doctorate from the University of Toronto. Sheldon’s commitment to philanthropy and leadership profoundly impacts families and youth.
Jon Sherron
Vice President – Business Development
With over 25 years of senior management experience, Jon Sherron has shaped strategic directions in the beverages, cannabis, and mining sectors. Known for his expertise in corporate governance, Jon continues to guide companies within the hemp, cannabis, and psychedelic sectors toward innovative growth.
Dr. Sazzad Hossain
Chief Technology Officer
With a rich background in biotech and pharmaceutical sectors, Dr. Sazzad Hossain has led the development of new natural health products that have generated substantial revenue. His leadership at InMed Pharmaceuticals as the Chief Scientific Officer and his academic prowess, including a PhD in Biology, make him a key player in Nirvana’s innovative drive.
Richard Monroe
Director
With an extensive background in finance and capital markets, Richard Monroe has led substantial growth initiatives in public finance and banking. His tenure as Chief Investment Officer at the Coastal Villages Region Fund saw the net worth grow significantly, demonstrating his financial acumen and strategic investment capabilities.
Mark Marissen
Director
A seasoned public affairs strategist, Mark Marissen has successfully guided numerous political and corporate leaders across Canada. Co-founder of Pacific Futures Energy Corp. and Senior Advisor to McMillan Vantage Policy Group, Mark’s expertise in navigating complex public narratives and strategic consulting has made him a vital asset to Nirvana.
